Cargando…
Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapy
Gene therapy using adeno-associated virus (AAV)-based vectors has become a realistic therapeutic option for hemophilia. We examined the potential of a novel engineered liver-tropic AAV3B-based vector, AAV.GT5, for hemophilia B gene therapy. In vitro transduction with AAV.GT5 in human hepatocytes was...
Autores principales: | Kashiwakura, Yuji, Endo, Kazuhiro, Ugajin, Atsushi, Kikuchi, Tomohiro, Hishikawa, Shuji, Nakamura, Hitoyasu, Katakai, Yuko, Baatartsogt, Nemekhbayar, Hiramoto, Takafumi, Hayakawa, Morisada, Kamoshita, Nobuhiko, Yamazaki, Shoji, Kume, Akihiro, Mori, Harushi, Sata, Naohiro, Sakata, Yoichi, Muramatsu, Shin-ichi, Ohmori, Tsukasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491835/ https://www.ncbi.nlm.nih.gov/pubmed/37693948 http://dx.doi.org/10.1016/j.omtm.2023.08.016 |
Ejemplares similares
-
Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A
por: Hiramoto, Takafumi, et al.
Publicado: (2023) -
A sensitive and reproducible cell-based assay via secNanoLuc to detect neutralizing antibody against adeno-associated virus vector capsid
por: Baatartsogt, Nemekhbayar, et al.
Publicado: (2021) -
PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells
por: Hiramoto, Takafumi, et al.
Publicado: (2023) -
Characterization and visualization of murine coagulation factor VIII-producing cells in vivo
por: Hayakawa, Morisada, et al.
Publicado: (2021) -
Development of an AAV DNA-based synthetic vector for the potential gene therapy of hemophilia in children
por: Shoti, Jakob, et al.
Publicado: (2022)